Guangzhou Fineimmune Biotechnology Co., Ltd.

This is an early-stage safety study testing a new type of personalized cell therapy for patients with advanced liver cancer. The therapy, called 'Super CAR-T,' involves modifying a patient's own immune cells to target a specific protein (GPC3) found on their cancer cells. The mai…

This is an early-stage safety study testing a new personalized cell therapy for adults with advanced sarcoma, lung cancer, or melanoma. Doctors take a patient's own immune cells, modify them in a lab to better target a specific protein found on their cancer cells, and then infuse…